Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / GTBP - GT Biopharma falls 21% after CEO and CFO leave company

GTBP - GT Biopharma falls 21% after CEO and CFO leave company

GT Biopharma Inc.
Shares of GT Biopharma (GTBP -20.7%) are down significantly today after the company said CEO Anthony Cataldo and CFO Michael Handelman have left the company. The company's board has appointed Gregory Berk and Gavin Choy, respectively, as acting CEO and CFO. GT also appointed Stacy Herb to SVP, portfolio management, and Leslie Bransfield to VP of chemistry, manufacturing, and control  and pharmaceutical sciences. Year to date, GT shares are down ~4%. In September, GT was issued two patents covering the company's TriKE platform technologies.

For further details see:

GT Biopharma falls 21% after CEO and CFO leave company
Stock Information
Company Name: GT Biopharma Inc.
Stock Symbol: GTBP
Market: OTC
Website: gtbiopharma.com
Menu
GTBP GTBP Quote GTBP Short GTBP News GTBP Articles GTBP Message Board
Get GTBP Alerts

News, Short Squeeze, Breakout and More Instantly...